Search Results for "Tingkatan Satu Sejarah Nota"

23:33 EDT 26th March 2015 | BioPortfolio

Matching Channels

None

Matching News

Don't worry, be happy: Just go to bed earlier

When you go to bed, and how long you sleep at a time, might actually make it difficult for you to stop worrying. So say Jacob Nota and Meredith Coles of Binghamton University in the US, who found that...

Don't worry, be happy; just go to bed earlier

(Binghamton University) When you go to bed and how long you sleep at a time might actually make it difficult for you to stop worrying, according to researchers at Binghamton University. The study, led...

ValiRx CEO on upcoming trial

Dr Satu Vainikka, chief executive of ValiRx (LON:VAL), talks to Proactive Investors about the cancer drug group’s upcoming trial, having just received the go-ahead. The Phase I/II study is for V...

The devil's helmet for a legendary tiger moth

(Pensoft Publishers) The Menetries' tiger moth (Borearctia menetriesii) is the most rare and enigmatic representative among the Palearctic Arctiinae. During an expedition in almost inaccessible wild t...

ValiRx expects first results from prostate drug trial in first quarter of next year

Drug developer ValiRx (LON:VAL) said it hopes to have the first results from its phase I/II study on its key asset, VAL201, in the first quarter of next year. The data will relate to the safety and to...

Better Sleep Could Help Those Overwhelmed By Negative Thoughts

Chuck Bednar for redOrbit.com - Your Universe Online Those who go to bed extremely late at night and sleep for shorter periods of time are more likely to feel more consumed by worry, researchers from...

ValiRx's equity swap agreement with Yorkville comes to an end

ValiRx (LON:VAL) said its equity swap funding arrangement with Yorkville has been terminated early. The arrangement was entered into at the end of 2013 and has been exercised in full by agreement betw...

ValiRx makes milestone payment as lead compound progresses

Drug developer ValiRx (LON:VAL) has paid £80,000 to Cancer Research Technology after lead drug VAL201 passed first patient dosing in its ongoing phase/II trial. CRT took the milestone payment in...

Matching PubMed Articles

A 67/68Ga-labeling agent that liberates 67/68Ga-NOTA-methionine by lysosomal proteolysis of parental low molecular weight polypeptides to reduce renal radioactivity levels.

The renal localization of gallium-67 or gallium-68 (67/68Ga)-labeled low molecular weight (LMW) probes such as peptides and antibody fragments constitutes a problem in targeted imaging. Wu et al. prev...

Comparison of 18F-AIF-NOTA-PRGD2 and 18F-FDG Uptake in Lymph Node Metastasis of Differentiated Thyroid Cancer.

A widespread application of integrin αvβ3 imaging has been emerging in both pre-clinical and clinical studies. But few studies reported its value as compared with 18F-FDG PET, especially for differe...

The Effect of Mini-PEG-Based Spacer Length on Binding and Pharmacokinetic Properties of a 68Ga-Labeled NOTA-Conjugated Antagonistic Analog of Bombesin.

The overexpression of gastrin-releasing peptide receptor (GRPR) in cancer can be used for peptide-receptor mediated radionuclide imaging and therapy. We have previously shown that an antagonist analog...

PET of Follicle-Stimulating Hormone Receptor: Broad Applicability to Cancer Imaging.

Follicle-stimulating hormone receptor (FSHR) is selectively overexpressed by the vascular endothelium in a wide variety of tumors and confirmed to play critical roles in angiogenesis, tumor invasion, ...

Comparison of Two Site-Specifically 18F-Labeled Affibodies for PET Imaging of EGFR Positive Tumors.

The epidermal growth factor receptor (EGFR) serves as an attractive target for cancer molecular imaging and therapy. Our previous PET studies showed that the EGFR-targeting Affibody molecules 64Cu-DOT...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement